1. Background
2. Objectives
3. Methods
3.1. Study Design
3.2. Setting and Population
3.3. Inclusion and Exclusion Criteria
3.4. Data Collection
3.5. Statistical Analysis
4. Results
4.1. Demographics and Clinical Information
| Variables | Total | Before COVID-19 Pandemic | During COVID-19 Pandemic | P |
|---|---|---|---|---|
| Mean age (mo) | 108.9 | 110.9 (9 - 204) | 107.1 (8 - 204) | 0.344 b |
| Gender | ||||
| Male | 235 (64.3) | 111 (64.5) | 124 (64.2) | 0.955 |
| Female | 130 (35.7) | 61 (35.5) | 69 (35.8) | 0.955 |
| Clinical signs and symptomsc | ||||
| Fever | 56 (16.5) | 6 (3.5) | 50 (29.9) | 0.001 |
| Anorexia | 229 (67.6) | 121 (69.9) | 108 (65.1) | 0.337 |
| Nausea/Vomiting | 261 (76.8) | 130 (75.1) | 131 (78.4) | 0.472 |
| Periumbilical pain | 212 (62.4) | 102 (59.0) | 110 (65.9) | 0.189 |
| Diarrhea | 14 (4.1) | 2 (1.2) | 12 (7.2) | 0.006 |
| Constipation | 9 (2.7) | 1 (0.6) | 8 (4.8) | 0.016 |
| RLQ pain | 233 (68.5) | 87 (50.3) | 146 (87.4) | 0.000 |
| Pain migration | 129 (37.9) | 35 (20.2) | 94 (56.3) | 0.000 |
| Symptom duration (days average) | 1.92 ± 2.1 | 2.14 ± 2.9 | 1.77 ± 1.45 | 0.137 |
| Physical signs | ||||
| RLQ tenderness | 313 (93.4) | 145 (97.3) | 168 (90.3) | 0.96 |
| Peritonitis | 10 (3.0) | 3 (2) | 7 (3.8) | 0.96 |
| Other e | 12 (3.6) | 1 (0.7) | 11 (5.9) | 0.96 |
| Imaging procedures | ||||
| Plain abdominal X-ray only | 51 (15.6) | 44 (27.8) | 7 (4.1) | 0.000 |
| Ultrasonography | 274 (83.8) | 113 (71.5) | 161 (95.3) | 0.000 |
| Computed tomography | 2 (0.6) | 1 (0.6) | 1 (0.6) |
Abbreviations: COVID-19, coronavirus disease 2019; RLQ pain, right lower quadrant pain.
a Values are expressed as No. (%) or mean ± SD.
b P-value estimated by the independent t-test.
c These values were calculated by the chi-square test.
e Includes abdominal distention and the presence of tender or non-tender masses in the right iliac fossa
4.2. Comparison of Perioperative Data
| Variables | Total | Before COVID-19 Pandemic | During COVID-19 Pandemic | P |
|---|---|---|---|---|
| Preoperative | ||||
| Laboratory findings | ||||
| Leukocytes (WBC) | 13636 ± 9501 | 15059 | 12308 | 0.007 |
| Neutrophils | 74.35 ± 13.11 | 74.21 ± 13.6 | 74.46 ± 12.6 | 0.863 |
| Lymphocytes | 20.29 ± 12.3 | 21.47 ± 12.9 | 19.23 ± 11.7 | 0.096 |
| NLR | 5.8 ± 4.7 | 5.5 ± 4.6 | 6.05 ± 4.8 | 0.292 |
| Ultrasound findings | 0.006 | |||
| Dilated non-compressible appendix | 178 (67.9) | 76 (74.5) | 102 (63.7) | |
| Intraabdominal fluid | 15 (5.7) | 9 (8.8) | 6 (3.8) | |
| Mesenteric lymphadenitis | 17 (6.5) | 9 (8.8) | 8 (5.0) | |
| Appendicular bbscess | 4 (1.5) | 1 (1.0) | 3 (1.9) | 0.378 |
| Phlegmon | 5 (1.9) | 0 | 5 (3.1) | 0.034 |
| Normal | 42 (16) | 7 (6.9) | 35 (21.9) | |
| Intraoperative | 0.002 | |||
| Operative procedures | ||||
| Open appendectomy | 340 (93.2) | 170 (98.3) | 170 (88.5) | |
| Laparotomy | 15 (4.1) | 3 (1.7) | 12 (6.3) | |
| Successful LA | 8 (2.2) | 1 (1.0) | 7 (2.0) | |
| LA required conversion | 2 (0.5) | 0 | 2 (1.0) | |
| Drain used? | 33 (9.0) | 11 (6.4) | 22 (11.5) | 0.090 |
| Intraoperative diagnosis | ||||
| Acute Apx | 175 (47.9) | 112 (64.7) | 63 (32.8) | 0.000 |
| Suppurative Apx | 112 (30.7) | 23 (13.3) | 89 (46.4) | 0.000 |
| Gangrenous Apx | 53 (24.5) | 27 (15.6) | 26 (13.5) | 0.522 |
| Abscess | 22 (6.0) | 8 (4.6) | 14 (7.3) | 0.308 |
| Postoperative | ||||
| Pathology report | 0.000 | |||
| Early acute Apx | 39 (14.1) | 6 (7.1) | 33 (17.3) | 0.000 |
| Acute Apx | 83 (30.1) | 51 (60) | 32 (16.8) | 0.003 |
| Suppurative Apx | 85 (30.8) | 17 (20) | 68 (35.6) | 0.000 |
| Gangrenous Apx | 51 (18.5) | 10 (11.8) | 41 (21.5) | 0.000 |
| Perforated Apx | 7 (2.5) | 1 (1.2) | 6 (3.1) | 0.081 |
| Vermiform | 11 (4) | 0 | 11 (5.8) | 0.000 |
| Hospitalization (h) | ||||
| < 24 | 18 (5.3) | 11 (7.6) | 7 (3.6) | 0.101 |
| > 24 | 322 (94.7) | 134 (92.4) | 189 (96.4) | 0.163 |
Abbreviations: COVID-19, coronavirus disease 2019; WBC, elevated white blood cell count; NLR, neutrophil-to-lymphocyte ratio; LA, laparoscopic appendectomy; Apx, appendicitis.
a Values are expressed as mean ± SD or No. (%).
4.3. Complicated Appendicitis
The monthly trend of complicated appendicitis. The left graph represents the pre-pandemic era, showing a descending rate of complicated acute appendicitis from February to July. On the other hand, the right graph (peri-pandemic era) shows increased rates of complicated acute appendicitis in these months.
4.4. Screening Methods
| Methods | No. (%) |
|---|---|
| Screening methods | |
| Lung CT | 107 (54.6) |
| X-ray + CBC | 69 (35.2) |
| PCR | 10 (5.1) |
| Lung CT + PCR | 3 (1.5) |
| Nothing | 3 (0.5) |
| PCR before surgery | |
| Positive | 4 (2) |
| Negative | 9 (4.6) |
| Not done | 177 (90.3) |
| Lung CT | |
| Positive | 1 (0.8) |
| Negative | 119 (99.2) |
| PCR after surgery | |
| Positive | 2 (1.1) |
| Negative | 5 (2.6) |
| Not done | 183 (96.3) |
| Suspected COVID-19 symptoms | |
| Fever | 56 (28.6) |
| Exhaustion | 3 (1.5) |
| Myalgia | 1 (0.5) |
| None | 130 (66.3) |
| Mean admission time (days) | 3.34 ± 2.2 |
| Positive COVID-19 | 8.0 a |
| Negative COVID-19 | 3.29 a |
Abbreviations: CT, computed tomography; CBC, complete blood count; PCR, polymerase chain reaction; COVID-19, coronavirus disease 2019.
a P = 0.000

